Skip navigation

Explore the Impact of Copay Accumulators, Maximizers and Drug Pricing Legislation on Patient Affordability

October 2-4, 2019
  • Philadelphia, PA

The pivotal discussion on the future of patient assistance, access and copay programs’ role will be front and center at CBI’s 7th Annual Coupon and Copay meeting. As the costs of specialty therapies rise and value-based healthcare takes hold, coupon and copay programs offer affordable access to high-cost therapies.

Discover the latest insights on the future of coupon and copay programs from industry practitioners and pioneering thought-leaders as they explore effective strategies to address the impact copay accumulator programs and high deductible health plans are having on patient access, adherence and affordability.

Join the Dialogue and Learn:

  • Analyze state and federal progress regulating
    copay accumulator programs —
    Understand the impact on employer sponsored health plans
  • Explore alternative copay strategies to respond to the rise of
    copay accumulator and maximizer programs
  • Assess how benefit plan design today can shift over the
    next 2-5 years and why
  • Examine the status of drug pricing legislation and the
    potential impact on patient access
  • Adapt and innovate copay program design to address
    patient affordability and access challenges
  • Determine the true impact of copay assistance programs on
    overall healthcare costs
  • Consider the impact of the price transparency debate and
    consumerism on patient adherence rates
  • Implement performance metrics to justify the cost of
    copay programs

Previous Attendee Acclaim:

Excellent variety of perspectives from speakers.

Sr. Product Manager, Prime Therapeutics

CBI is a great gathering of industry leaders. I always walk away with valuable new information and connections. Thank you CBI!

VP, Business Development, SingleCare Services LLC